Tenaya Therapeutics (NASDAQ:TNYA) Shares Gap Up to $18.41

Shares of Tenaya Therapeutics Inc (NASDAQ:TNYA) gapped up before the market opened on Thursday . The stock had previously closed at $18.41, but opened at $19.05. Tenaya Therapeutics shares last traded at $18.74, with a volume of 942 shares changing hands.

A number of analysts have recently commented on the stock. Piper Sandler assumed coverage on shares of Tenaya Therapeutics in a report on Tuesday, August 24th. They set an “overweight” rating and a $40.00 target price on the stock. Cowen assumed coverage on shares of Tenaya Therapeutics in a report on Tuesday, August 24th. They set an “outperform” rating on the stock. Morgan Stanley began coverage on shares of Tenaya Therapeutics in a report on Tuesday, August 24th. They set an “overweight” rating and a $31.00 target price on the stock. Finally, Chardan Capital began coverage on shares of Tenaya Therapeutics in a research note on Tuesday, August 24th. They issued a “buy” rating and a $37.00 price target on the stock.

The stock has a 50 day moving average price of $21.97.

Tenaya Therapeutics (NASDAQ:TNYA) last posted its earnings results on Tuesday, September 7th. The company reported ($13.26) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by ($12.73). As a group, equities research analysts expect that Tenaya Therapeutics Inc will post -8.59 earnings per share for the current year.

Tenaya Therapeutics Company Profile (NASDAQ:TNYA)

Tenaya Therapeutics Inc is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company’s product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc is based in SOUTH SAN FRANCISCO, Calif.

Featured Article: Green Investing

Receive News & Ratings for Tenaya Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenaya Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.